Semax — Russian Academy nootropic peptide for neuroprotection
In short
Studied for how it may protect your brain and help you think more clearly, learn faster, and maintain better focus.
Overview
Semax is a synthetic heptapeptide derived from adrenocorticotropic hormone (ACTH) fragment 4-10, extensively studied for its nootropic, neuroprotective, and neurorestorative properties. Originally developed in Russia for stroke recovery, this brain-targeted peptide rapidly increases
Direct transport through olfactory epithelium and trigeminal nerves, bypassing blood-brain barrier for enhanced CNS penetration
Molecular information
Research indications
Grouped by area. Each entry reflects a separate published hypothesis or clinical signal - not medical advice.
Gusev et al. (Lancet Neurol 2008, n=160) - 6 mg/day within 4 h after stroke reduces disability by 25-30%.
Започнете с най-ниската ефективна доза от 300 мкг за оценка на индивидуалната реакция. Избягвайте едновременна употреба с други интраназални медикаменти, които причиняват вазоконстрикция. Наблюдавайте за признаци на назално дразнене, кървене или постоянен дискомфорт. Не превишавайте 4 седмици непрекъсната употреба без медицинско наблюдение. Намалете дозите на други стимуланти, тъй като пептидът може да засили техния ефект. Сигнали за спиране: Тежко назално дразнене, кървене или постоянна конгестия. Необичайна тревожност, възбуда или нарушения на съня. Главоболие, което се влошава при продължителна употреба. Всякакви признаци на алергична реакция като обрив или затруднено дишане. Значителни промени в кръвното налягане или сърцебиене.
3 peer-reviewed sources
References
Links to peer-reviewed publications on PubMed, cited in the peptide's scientific profile.
Shadrina - Transcriptome
Animal | 50 mcg/kg | single | 1500+ genes activated in hippocampus
BMC Genomics · 2010
View the studyInformation about Semax is based on published scientific research and is intended for research purposes only. Not medical advice.
Products are for in vitro laboratory research only. Not approved for human consumption.
Other peptides
5-Amino-1MQ
5-Amino-1MQ is a small-molecule selective inhibitor of NNMT (nicotinamide N-methyltransferase), identified by Anthony Sauve (Cornell) in 2018. NNMT is a "metabolic sink" for methyl donors and NAD+ — suppressing it in adipocytes raises energy expenditure without reducing calorie intake.
ReadAdipotide
Adipotide is a target peptide developed by Wadih Arap and Renata Pasqualini (MD Anderson) for selective elimination of white adipose tissue. It binds prohibitin on adipocyte vasculature and induces apoptosis of the blood vessels supplying fat tissue — leading to nonsurgical fat reduction.
ReadAOD-9604
AOD-9604 is a modified C-terminal 16-amino-acid fragment of human growth hormone (177-191), supplemented with a tyrosine residue. Retains the lipolytic effect of the full molecule but without diabetogenic or GH-stimulating activity. Developed by Metabolic Pharmaceuticals (Australia) in the 1990s.
ReadARA-290
ARA-290 (Cibinetide) is an 11-amino-acid fragment of erythropoietin (EPO) developed by Anthony Cerami as a cytoprotective molecule without erythropoietic activity. It retains the tissue-protective effects of EPO without raising hematocrit — explaining its potential in diabetic neuropathy and cardiac applications.
ReadArgireline
Argireline is a synthetic acetylated hexapeptide (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2) derived from SNAP-25 — the SNARE complex subunit mediating acetylcholine release at neuromuscular junctions. Topical application reduces muscle activity in expression areas — which is why Argireline is marketed as a "topical Botox alternative".
ReadBPC-157
BPC-157 is a 15-amino-acid fragment isolated from a protective protein in human gastric juice — hence the name Body Protection Compound. Over thirty years of research by Predrag Sikiric's group at the University of Zagreb (100+ peer-reviewed papers) establish its angiogenic action through the VEGFR2 receptor and its stimulation of fibroblasts. If you work with in vitro models of tendon, muscle or gut tissue, BPC-157 is among the most extensively documented regenerative peptides.
ReadEducation
No comments yet. Be the first.
Comments are reviewed before publishing.
